Riociguat Alleviates Cisplatin-Caused Kidney Injury by Suppressing Oxidative Stress and Inflammation
Biology · 02.10.2025 · 14 (10) · 1346
DOI: 10.3390/biology14101346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, online erschienen am 02.10.2025. Verfasst von Yousuf M Al Suleimani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Oman. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sultan Qaboos University.
Abstract (Originalsprache)
Background
Cisplatin (CP), a platinum-based chemotherapeutic agent, is widely used to treat cancer but causes nephrotoxicity. Riociguat, a soluble guanylate cyclase (sGC) stimulator that enhances the nitric oxide–sGC–cGMP signaling pathway, was investigated for its potential protective effects against cisplatin-induced nephrotoxicity. Materials and Methods: Rats were randomly divided into four equal groups (six rats each) and treated for nine consecutive days. The first and second groups were given oral carboxymethylcellulose 0.5% (vehicle) for 9 days, and on day 6 were injected intraperitoneally with saline or CP, respectively. The third and fourth groups were treated orally with two doses of riociguat (3 and 10 mg/kg/day) for 9 days, and received intraperitoneal injections of CP on day 6. Blood, urine, and kidney tissues were analyzed 24 h after the last treatment.
Results
CP significantly elevated the markers of kidney function, including uric acid, serum creatinine, and urea. CP also caused histological kidney damage. Antioxidant markers, including catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), and total antioxidant capacity (TAC) were significantly reduced, while inflammatory cytokines (IL-1β, IL-6, and TNF-α) and lipid peroxidation (MDA) were markedly increased. Riociguat improved kidney structure and significantly reduced kidney function markers, MDA, and inflammatory cytokines while restoring GR, TAC, SOD, and CAT activities.
Conclusions
These results indicate that riociguat exerts protection of the kidneys from CP-caused kidney damage by antioxidation and anti-inflammation. Riociguat may have potential as an adjunct therapy to mitigate CP-associated nephrotoxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Oman.
- Department of Animal and Veterinary Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Oman.
ORCID-Profile: Yousuf M Al Suleimani, Raya Al Maskari, Haytham Ali
Förderung
- Sultan Qaboos University
Zitieren
APA
Al Suleimani, Y. M., Nomeir, Y., Al Maskari, R., Ali, H., Manoj, P., & Abdelrahman, A. M. (2025). Riociguat Alleviates Cisplatin-Caused Kidney Injury by Suppressing Oxidative Stress and Inflammation. Biology, 14(10), 1346. https://doi.org/10.3390/biology14101346
Vancouver
Al Suleimani YM, Nomeir Y, Al Maskari R, Ali H, Manoj P, Abdelrahman AM. Riociguat Alleviates Cisplatin-Caused Kidney Injury by Suppressing Oxidative Stress and Inflammation. Biology. 2025;14(10):1346. doi:10.3390/biology14101346
BibTeX
@article{AlSuleimani2025,
author = {Al Suleimani, Yousuf M and Nomeir, Yousra and Al Maskari, Raya and Ali, Haytham and Manoj, Priyadarsini and Abdelrahman, Aly M},
title = {Riociguat Alleviates Cisplatin-Caused Kidney Injury by Suppressing Oxidative Stress and Inflammation},
journal = {Biology},
year = {2025},
volume = {14},
number = {10},
pages = {1346},
doi = {10.3390/biology14101346}
}
EUVIMED